Your browser doesn't support javascript.
loading
Tacrolimus Monotherapy is Safe in Immunologically Low-Risk Kidney Transplant Recipients: A Randomized-Controlled Pilot Study.
de Weerd, Annelies E; Fatly, Zainab Al; Boer-Verschragen, Marieken; Kal-van Gestel, Judith A; Roelen, Dave L; Dieterich, Marjolein; Betjes, Michiel G H.
Afiliação
  • de Weerd AE; Department of Internal Medicine, University Medical Center Rotterdam, Erasmus MC Transplant Institute, Rotterdam, Netherlands.
  • Fatly ZA; Department of Internal Medicine, University Medical Center Rotterdam, Erasmus MC Transplant Institute, Rotterdam, Netherlands.
  • Boer-Verschragen M; Department of Internal Medicine, University Medical Center Rotterdam, Erasmus MC Transplant Institute, Rotterdam, Netherlands.
  • Kal-van Gestel JA; Department of Internal Medicine, University Medical Center Rotterdam, Erasmus MC Transplant Institute, Rotterdam, Netherlands.
  • Roelen DL; Department of Immunology, HLA Laboratory, Leiden University Medical Center, Leiden, Netherlands.
  • Dieterich M; Department of Internal Medicine, University Medical Center Rotterdam, Erasmus MC Transplant Institute, Rotterdam, Netherlands.
  • Betjes MGH; Department of Internal Medicine, University Medical Center Rotterdam, Erasmus MC Transplant Institute, Rotterdam, Netherlands.
Transpl Int ; 35: 10839, 2022.
Article em En | MEDLINE | ID: mdl-36353052
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Rim / Tacrolimo Tipo de estudo: Clinical_trials / Etiology_studies / Risk_factors_studies Limite: Humans / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Rim / Tacrolimo Tipo de estudo: Clinical_trials / Etiology_studies / Risk_factors_studies Limite: Humans / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article